Antiaging compounds: (-)deprenyl (selegeline) and (-)1-(benzofuran-2-yl)-2-propylaminopentane, [(-)bpap], a selective highly potent enhancer of the impulse propagation mediated release of catecholamine and serotonin in the brain
by
Knoll J.
Department of Pharmacology,
Faculty of General Medicine,
Semmelweis University,
H-1445 Budapest, Hungary.
joszefknoll@hotmail.com
CNS Drug Rev 2001 Autumn;7(3):317-45

ABSTRACT

Hundreds of millions of people now die over the age of 80 years primarily due to twentieth century progress in hygiene, chemotherapy, and immunology. With a longer average lifespan, the need to improve quality of life during the latter decades is more compelling. "Aging - The Epidemic of the New Millenium," a recent international conference (Monte Carlo, June 17-18, 2000), showed with peculiar clarity that a safe and efficient drug strategy to slow the age-related decay of brain performance is still missing. This review summarizes the physiologic and pharmacologic arguments in favor of a peculiar lifelong prophylactic medication with reasonable chances to keep in check brain aging and decrease the precipitation of age-related neurological diseases.

(-)BPAP
Interactions
Propargylamines
Parkinson's disease
Alzheimer's disease
Selegiline and cocaine
Selegiline and the DAT
Selegiline and nitric oxide
Selegiline and life-expectancy
Selegiline for longer-lived flies
Selegiline: product information
Selegiline for cocaine dependence

Refs
HOME
HedWeb
BLTC Research
Paradise-Engineering
Utopian Pharmacology
The Hedonistic Imperative
When Is It Best to Take Crack Cocaine?